Arcutis Biotherapeutics, Inc. (ARQT)
29.79
+0.03
(+0.10%)
USD |
NASDAQ |
Dec 10, 16:00
29.85
+0.06
(+0.20%)
After-Hours: 18:32
Arcutis Biotherapeutics Profit Margin (Quarterly): 7.47% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 27.14% |
| ANI Pharmaceuticals, Inc. | 10.59% |
| CorMedix, Inc. | -- |
| Editas Medicine, Inc. | -333.0% |
| Syndax Pharmaceuticals, Inc. | -132.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.40% |
| Return on Assets | -11.96% |
| Return on Invested Capital | -15.75% |
| Gross Profit Margin (Quarterly) | 91.25% |
| Operating Margin (Quarterly) | 8.59% |
| Return on Net Operating Assets | -33.35% |